Sun Pharmaceutical Industries, the world’s fourth-largest specialty generic pharmaceutical company, officially launched its Primary Care Division in the Philippines with the unveiling of the CaRMeLin Portfolio — a comprehensive therapeutic line dedicated to Cardiometabolic, Renal, Liver, and Alimentary care. More